Schedule 13G ownership disclosure

UROGEN PHARMA LTD

Security class unavailable · CUSIP: M96088105

Event date: 2019-09-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
533,139
Percent of class
2.5500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001387131-19-007448
Form type
SC 13G
Filer
UroGen Pharma Ltd.
CIK
CIK 1668243
Filed
Oct 04, 2019
Reporting period
Sep 26, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub